| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tetratricopeptide repeat domain 33 | 0.931 | 0.115 | 5.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2011 | 2011 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 4 | 1999 | 2019 | ||||||||
|
POM121 transmembrane nucleoporin like 2 | 0.861 | 0.192 | 0.33 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2009 | 2019 | ||||||||
|
RAR related orphan receptor A | 0.533 | 0.808 | 0.40 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2012 | 2012 | ||||||||
|
autophagy and beclin 1 regulator 1 | 0.729 | 0.308 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 4 | 2012 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.440 | None | 1.000 | 3 | 3 | 2011 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2019 | |||||||||
|
serologically defined colon cancer antigen 8 | 0.619 | 0.577 | 1.2E-11 |
|
disease | 0.410 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
disease | 0.700 | None | 1.000 | 2 | 3 | 2011 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.120 | None | 1.000 | 2 | 3 | 2009 | 2020 | ||||||||
|
tetraspanin 18 | 0.792 | 0.231 | 8.2E-02 |
|
disease | 0.450 | None | 1.000 | 1 | 3 | 2011 | 2016 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 1 | 0.453 | 0.846 | 0.14 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2011 | 2011 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2011 | 2019 | ||||||||
|
piggyBac transposable element derived 1 | 0.821 | 0.269 | 4.7E-10 |
|
disease | 0.430 | None | 0.800 | 3 | 2 | 2011 | 2014 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.500 | None | 0.750 | 3 | 2 | 2000 | 2019 | ||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | |||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.500 | None | 1.000 | 2 | 2 | 2009 | 2018 | ||||||||
|
fasciculation and elongation protein zeta 1 | 0.666 | 0.500 | 0.75 |
|
disease | 0.500 | None | 0.667 | 2 | 2 | 2004 | 2017 | ||||||||
|
LRR binding FLII interacting protein 1 | 0.678 | 0.500 | 2.0E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
arsenite methyltransferase | 0.638 | 0.538 | 8.0E-11 |
|
disease | 0.140 | None | 0.889 | 1 | 2 | 2011 | 2019 | ||||||||
|
solute carrier family 17 member 1 | 0.760 | 0.462 | 4.1E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2009 | ||||||||
|
long intergenic non-protein coding RNA 2033 | 0.931 | 0.038 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | |||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2017 | ||||||||
|
solute carrier family 17 member 3 | 0.769 | 0.385 | 4.9E-22 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2015 |